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ABSTRACT:
The correlation between recurrent bleeding on
probing and the progression of periodontal destruction is
suggested in many studies. One of the main goals of the
periodontal treatment is the achievement of good control of
the gingival inflammation and the reduction of the active
periodontal sites.
Aim: Evaluation of the effectiveness of treatment of
severe chronic periodontitis with additional target antibiotic
administration in comparison with the therapy with
adjunctive antimicrobial combination amoxicillin +
metronidazole and conventional mechanical periodontal
treatment regarding the achieved control of the gingival
inflammation and BoP.
Results:  Significant reduction of the gingival
bleeding and the BoP is achieved in all groups. In the group
with target antibiotic administration the final mean values
of the GB (gingival bleeding) and BoP (bleeding on probing)
are the lowest and could suggest a low risk for progression
of the periodontal disease.
Key words: gingival inflammation, periodontitis,
periodontal disease progression, risk assessment.
BACKGROUND:
Periodontal disease is a common inflammatory
disease, characterized by loss of the tooth supporting
structures, the connective tissue attachment, and alveolar
bone. Progressive loss of matrix constituents leading to bone
resorption is an essential factor in the loss of tooth
supporting tissues. Plaque biofilm and associated host
response are the key elements in the pathogenesis of
periodontitis (2, 6, 7, 10, 11).
It has become quite clear that periodontitis is a
multifactorial disease initiated by microorganisms
accumulating in the dentogingival area (3, 4).
Conventional anti-infectious treatment modalities of
periodontal diseases include mechanical removal of
microbial plaque and calculus by scaling and root planing
(5).
Yet, some cases may need adjunctive chemical
treatment (9, 12).
 Treatment of periodontal diseases by means of
chemical adjuncts has addressed the better control of
infection using antibiotics and antimicrobials as well as the
control of tissue destruction using various host modulators.
The correlation between recurrent bleeding on
probing and the progression of periodontal destruction is
suggested in many studies. One of the main goals of the
periodontal treatment is the achievement of good control of
the gingival inflammation and the reduction of the active
periodontal sites. Although there is no established acceptable
level of prevalence of BoP in the dentition above which a
higher risk for disease recurrence has been observed, a BoP
prevalence of 25% has been the cut-off point between
patients with maintained periodontal stability for 4 years and
patients with recurrent disease in the same time frame.
Individuals with low mean BoP percentages (<10% of the
sites) may be regarded as patients with a low risk for
recurrent disease while patients with mean BOP percentages
>25% should be considered to be at high risk for reinfection.
The reduction of GB and BoP prevalence below 25% in the
end of periodontal treatment may be evaluated as a sign of
successful periodontal therapy (1, 8).
AIM:
Evaluation of the effectiveness of treatment of severe
chronic periodontitis with additional target antibiotic
administration in comparison with the therapy with
adjunctive antimicrobial combination amoxicillin+
metronidazole and conventional mechanical periodontal
treatment regarding the achieved control of the gingival
inflammation and BoP.
MATERIALS AND METHODS:
Patients with active periodontal disease with 3468
affected sites were recruited in this study. Inclusion criteria
were at least 20 teeth, 6 sites with PD>5mm, 2 sites with
PD>7mm in different dentition quadrants. Exclusion criteria
were pregnancy, lactation, systemic antibiotic treatment in
DOI: 10.5272/jimab.1642010_18-20  / JofIMAB; Issue: vol. 16, book 4, 2010 /  19
the previous 3 months. The patients were divided in three
groups:
•  Test group 1 (TG1) – patents with 834 affected sites
- conventional mechanical periodontal therapy and
adjunctive broad spectrum systemic antibiotic treatment
(Amoxicillin 500mg/Metronidazol 250mg – tid for 10 days.
•  Test group 2 (TG2) – patents with 1110 affected
sites - conventional mechanical periodontal therapy and
adjunctive specific systemic antibiotic administration after
microbiological testing for susceptibility.
•  Control group (CG) – patients with 1524 affected
sites -   conventional mechanical periodontal therapy only.
Clinical parameters:
A full range of periodontal diagnostic measurements
were registered before and after treatment. The collected
data includes: Hygiene Index (HI), Gingival bleeding index
(GBI), Probing depth (PD), Clinical attachment level (CAL),
Gingival recession (R), Furcation involvement (F) and
Mobility (M) were carried out  all patients. The
measurements were registered on six points on every tooth
(mesiobuccal, buccal, distobuccal, distolingual, lingual,
mesiolingual) with Williams’s periodontal probe. The
alveolar bone loss was registered on panoramic, segment and
bite-wing x-rays.
RESULTS:
Significant reduction of the gingival bleeding and the
BoP is achieved in all groups. In the group with target
antibiotic administration the final mean values of the GB
(gingival bleeding) and BoP (bleeding on probing) are the
lowest and could suggest a low risk for progression of the
periodontal disease.
The reduction of the gingival inflammation is one of
the major indicators of the successful periodontal treatment.
The collected data concerning the gingival status (GBI, BoP)
is presented on the following charts.  The reduction of the
GBI (46,52% TG1; 48,87% TG2, 48,29% CG) and BoP
(54,14% TG1; 56,83% TG2, 60,28% CG) is similar in all
groups and presents the achieved satisfying control of the
gingival inflammation. In TG2 the mean value of the BoP
prevalence after treatment is the lowest (12,46%) compared
with the TG1 (20,46%) and CG (15,67%) which defines the
lowest risk of progression of the periodontal disease for
TG2.
Chart 1. Rreduction of the gingival bleeding and the
BoP in correlation with the increase of the free of plaque
surfaces in test group 1.
Chart 2. Rreduction of the gingival bleeding and the
BoP in correlation with the increase of the free of plaque
surfaces in test group 2.20  / JofIMAB; Issue: vol. 16, book 4, 2010 /
CONCLUSION:
Significant reduction of the gingival bleeding and the
BoP is achieved in all groups. In the group with target
antibiotic administration the final mean values of the GB
(gingival bleeding) and BoP (bleeding on probing) are the
lowest and could suggest a low risk for progression of the
periodontal disease.
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